How should I diagnose non‑asthmatic eosinophilic bronchitis in a 35‑year‑old woman with a 30‑day productive cough?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Non-Asthmatic Eosinophilic Bronchitis

Diagnose non-asthmatic eosinophilic bronchitis by documenting sputum eosinophilia ≥3% on induced sputum analysis after excluding other causes of chronic cough through spirometry showing normal airflow and methacholine challenge testing demonstrating normal airway responsiveness (PC20 >16 mg/mL). 1

Diagnostic Criteria

Non-asthmatic eosinophilic bronchitis requires all of the following features 1:

  • Chronic cough (≥8 weeks duration, though your patient's 30-day cough is approaching this threshold) 1
  • No symptoms or objective evidence of variable airflow obstruction (normal spirometry) 1
  • Normal airway hyperresponsiveness on methacholine challenge (PC20 >16 mg/mL) 1
  • Sputum eosinophilia ≥3% of non-squamous cells 1

Step-by-Step Diagnostic Algorithm

Step 1: Exclude Other Causes of Chronic Cough

Before pursuing sputum analysis, perform 1:

  • Clinical assessment: Look for post-nasal drip symptoms, gastroesophageal reflux symptoms, or medication-induced cough (ACE inhibitors)
  • Chest radiograph: Rule out structural lung disease, malignancy, or infection
  • Spirometry with bronchodilator: Must show normal FEV1/FVC ratio and no significant bronchodilator response (excludes asthma) 1

Step 2: Perform Methacholine Challenge Testing

This is essential to differentiate non-asthmatic eosinophilic bronchitis from cough-variant asthma 1:

  • Normal result (PC20 >16 mg/mL) supports non-asthmatic eosinophilic bronchitis
  • Positive result (PC20 ≤16 mg/mL) indicates cough-variant asthma instead
  • The absence of airway hyperresponsiveness is the key distinguishing feature from asthma 1

Step 3: Document Sputum Eosinophilia

Induced sputum analysis is the gold standard diagnostic test 1, 2, 3:

Sputum induction technique 1:

  • Premedicate with a short-acting bronchodilator
  • Patient inhales hypertonic saline (3%, 4%, then 5%) for 5 minutes each via ultrasonic nebulizer
  • Expectorated sputum is processed with mucolytic agent, filtered through 48-μm mesh, and centrifuged
  • Count 400 non-squamous cells on cytospin preparation
  • ≥3% eosinophils is diagnostic (normal is <1.1%) 1

Important technical considerations 1:

  • Requires same-day processing for accurate cell counts and viability
  • Safe and repeatable procedure
  • May also identify neutrophilia from bacterial/viral bronchitis

Alternative if sputum induction unavailable or unsuccessful 1:

  • Bronchoscopy with bronchial wash fluid provides similar information to induced sputum 1

Key Distinguishing Features from Related Conditions

The ACCP guidelines provide clear differentiation 1:

Feature Non-Asthmatic Eosinophilic Bronchitis Cough-Variant Asthma Classic Asthma
Airway hyperresponsiveness Absent Present Present
Bronchodilator response Absent Good Good
Spirometry Normal Normal Abnormal
Sputum eosinophilia Always present Usually present Usually present

Common Pitfalls to Avoid

Do not rely on clinical features alone 1:

  • The nature and timing of cough provides limited diagnostic help
  • Physical examination is typically normal
  • Upper airway symptoms may be present but are non-specific

Always consider multiple causes 1:

  • Non-asthmatic eosinophilic bronchitis accounts for 10-30% of chronic cough cases referred for specialist evaluation 1
  • Multiple causes often coexist, so continue investigating even if another cause is identified
  • Consider non-asthmatic eosinophilic bronchitis if there is no response or only partial response to treatment of another identified cause 1

Exhaled nitric oxide has limitations 1:

  • While elevated in some cases, it is not sufficiently validated as a standalone diagnostic test for non-asthmatic eosinophilic bronchitis
  • Sputum eosinophil count remains the definitive test 1, 2

Special Considerations for Your 35-Year-Old Patient

The 30-day duration is shorter than the typical 8-week definition of chronic cough 1:

  • Consider treating acute/subacute causes first (post-viral cough, acute bronchitis)
  • If cough persists beyond 8 weeks, proceed with full diagnostic workup for non-asthmatic eosinophilic bronchitis

Productive cough is consistent with the diagnosis 1:

  • Non-asthmatic eosinophilic bronchitis often presents with cough and sputum production
  • The productive nature allows for spontaneous sputum collection if available, though induced sputum is more reliable 1, 4

Consider occupational or allergen exposure 1:

  • Ask specifically about workplace exposures to sensitizers
  • Inquire about new environmental allergen exposures
  • These may be treatable causes requiring allergen avoidance 1, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nonasthmatic Eosinophilic Bronchitis: A Systematic Review of Current Treatment Options.

Journal of investigational allergology & clinical immunology, 2024

Research

Non-astmatic Eosinophilic Bronchitis.

Turkish thoracic journal, 2018

Research

Clinical features of eosinophilic bronchitis.

The Korean journal of internal medicine, 2002

Related Questions

What is the treatment for nonasthmatic eosinophilic bronchitis?
What is the approach to a patient with a chronic cough, sputum production, and shortness of breath (SOB) on exertion, with a baseline eosinophil count of 54%?
What is the initial management for a patient presenting with cough and inspiratory wheezing?
What is the treatment for bronchitis?
What is the most appropriate next step in management for a child with a history of atopic dermatitis (eczema) who presents with cough and wheezing following an upper respiratory tract infection (URTI) and has had similar episodes in the past?
Can fenofibrate be administered at 300 mg daily in an adult with triglycerides of 1000 mg/dL?
What fenofibrate capsule strengths are commercially available, and what is the appropriate dose for an adult patient with a triglyceride level of approximately 1000 mg/dL and normal renal function?
In a newborn who is Rh‑positive (O+) delivered by an Rh‑negative (O‑) mother, should anti‑D (Rho(D) immune globulin) be given to the mother, the baby, both, or neither?
How should I manage a child aged 6 months to 5 years presenting with classic croup (barking cough, hoarse voice, inspiratory stridor)?
What is the appropriate evaluation and management for recurrent wheezing in a 12‑month‑old child?
In a patient taking dabigatran who requires anesthesia, how should the drug be managed—including timing of discontinuation based on creatinine clearance and surgical bleeding risk, use of idarucizumab for urgent cases, neuraxial block timing, and when to restart anticoagulation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.